Insider Transactions in Q3 2022 at Ironwood Pharmaceuticals Inc (IRWD)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 15
2022
|
Alexander J Denner |
BUY
Grant, award, or other acquisition
|
Direct |
1,374
+1.49%
|
-
|
|
Sep 01
2022
|
Thomas A Mccourt Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
26,446
-3.49%
|
$264,460
$10.65 P/Share
|
|
Aug 15
2022
|
Ronald Silver Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,014
-1.88%
|
$22,154
$11.77 P/Share
|
|
Aug 15
2022
|
Jason Rickard SVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
994
-0.26%
|
$10,934
$11.77 P/Share
|
|
Aug 15
2022
|
Minardo John Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
7,330
-4.96%
|
$80,630
$11.77 P/Share
|
|
Aug 11
2022
|
Mark G Currie |
SELL
Open market or private sale
|
Direct |
70,000
-11.83%
|
$770,000
$11.78 P/Share
|
|
Aug 09
2022
|
Jason Rickard SVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
18,041
-4.57%
|
$198,451
$11.75 P/Share
|
|
Aug 09
2022
|
Jason Rickard SVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,041
+4.37%
|
$198,451
$11.65 P/Share
|
|
Aug 08
2022
|
Jason Rickard SVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
29,436
-3.64%
|
$323,796
$11.6 P/Share
|
|
Aug 01
2022
|
Thomas A Mccourt Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
23,229
-2.97%
|
$255,519
$11.35 P/Share
|